Results of hepatic resection for hepatocellular carcinoma invading major portal and/or hepatic veins

Surgical Oncology Clinics of North America

Volumn 12, Issue 1, 2003, Pages 65-75

  Ikai, Iwao ^a   Yamamoto, Yuzo ^a   Yamamoto, Naritaka ^a   Terajima, Hiroaki ^a   Hatano, Etsuro ^a   Shimahara, Yasuyuki ^a   Yamaoka, Yoshio ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CANCER INVASION; CANCER PALLIATIVE THERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; FEMALE; HEPATIC VEIN; HUMAN; LIVER CELL CARCINOMA; LIVER DYSFUNCTION; LIVER LOBECTOMY; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PARTIAL HEPATECTOMY; PORTAL VEIN; PROGNOSIS; REVIEW; SURGICAL MORTALITY; TUMOR THROMBUS; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEASIBILITY STUDIES; FEMALE; HEPATECTOMY; HEPATIC VEINS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PORTAL VEIN; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VASCULAR NEOPLASMS;

EID: 0037264883     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1055-3207(02)00082-0     Document Type: Review

References (35)

1. Okuda K. Hepatocellular carcinoma: recent progress. Hepatology 1992;15:948-63.
2. Takayasu K, Moriyama N, Muramatsu Y, et al. The diagnosis of small hepatocellular carcinomas: efficacy of various imaging procedures in 100 patients. Am J Roentgenol 1990;155:49-54.
3. Curley SA, Izzo F, Ellis LM, et al. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 2000;232:381-91.
4. Livraghi T, Giorgio A, Marin G, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995;197:101-8.
5. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-8.
6. Takayasu K, Wakao F, Moriyama N, et al. Postresection recurrence of hepatocellular carcinoma treated by arterial embolization: analysis of prognostic factors. Hepatology 1999;16:906-11.
7. Yamada R, Kishi K, Sato M, et al. Transcatheter arterial chemoembolization (TACE) in the treatment of unresectable liver cancer. World J Surg 1995;19:795-800.
8. Mori K, Ozawa K, Yamamoto Y, et al. Response of hepatic mitochondrial redox state to oral glucose load-redox tolerance test as a new predictor of surgical risk in hepatectomy. Ann Surg 1990;211:438-46.
9. Kumada K, Ozawa K, Okamoto R, et al. Hepatic resection for advanced hepatocellular carcinoma with removal of the portal vein tumor thrombi. Surgery 1990;180:821-7.
10. Kumada K, Shimahara Y, Fukui K, et al. Extended right hepatic lobectomy: combined resection of IVC and its reconstruction by ePTFE graft (Gore-Tex). Acta Chir Scand 1988;154:481-3.
11. Yamaoka Y, Ozawa K, Tanaka A, et al. New device for harvesting a hepatic graft from a living donor. Transplantation 1991;52:157-60.
12. Yamaoka Y, Ozawa K, Kumada K, et al. Total vascular exclusion for hepatic resection in cirrhotic patients. Arch Surg 1992;127:276-80.
13. Kiuchi T, Ozawa K, Yamamoto Y, et al. Changes in arterial ketone body ratio in the phase immediately after hepatectomy. Arch Surg 1990;125:655-59.
14. Ozawa K, Aoyama H, Yasuda K, et al. Metabolic abnormalities associated with postoperative organ failure. Arch Surg 1983;118:1245-51.
15. Ikai I, Yamaoka Y, Yamamoto Y, et al. Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastasis. Ann Surg 1998;227:433-9.
16. Liver Cancer Study Group of Japan. Classification of primary liver cancer (first English edition). Tokyo: Kanehara & Co; 1997.
17. Couinaud C. Plaidoyer pour une segmentation hepatique exacte et une technique anatomique de resection reglee du foie. Presse Med 1966;74:2849-52.
18. Liver Cancer Study Group of Japan. Predictive factors for long-term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer 1994;74:2772-80.
19. Tsai TJ, Chau GY, Lui WY, et al. Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery 2000;127:603-8.
20. Vauthey JN, Klimstra D, Franceschi D, et al. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg 1995;169:28-35.
21. Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Ann Surg 1990;211:277-87.
22. Llovet JM, Bustanante J, Castells A, et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 1999;29:62-7.
23. Okada S, Okazaki N, Nose H, et al. Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Hepatology 1992;16:112-7.
24. Allgaier HP, Deibert P, Olschewski M, et al. Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection - a single-center analysis including 132 patients. Int J Cancer 1998;79:601-5.
25. Schwartz ME, Sung M, Mor E, et al. Multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis. J Am Coll Surg 1995;180:596-603.
26. Nagasue N, Yukaya H, Ogawa Y, et al. Clinical experience with 118 hepatic resections for hepatocellular carcinoma. Surgery 1986;99:694-701.
27. Midorikawa Y, Kubota K, Takayama T, et al. A comparative study of postoperative complications after hepatectomy in patients with and without chronic liver disease. Surgery 1999;126:484-91.
28. Yasui M, Harada A, Torii A, et al. Impaired liver function and long-term prognosis after hepatectomy for hepatocellular carcinoma. World J Surg 1995;19:439-43.
29. Iwatsuki S, Dvorchik I, Marsh JW, et al. Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 2000;191:389-94.
30. Ringe B, Pichlmayr R, Wittekind C, et al. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg 1991;15:270-85.
31. Lee HS, Kim JS, Choi IJ, et al. The safety and efficacy of transeatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. Cancer 1997;79:2087-94.
32. Minagawa M, Makuuchi M, Takayama T, et al. Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Ann Surg 2001;233:379-84.
33. Ando E, Yamashita F, Tanaka M, et al. A novel chemotherapy for advanced hepatocellular carcinoma with tumor thrombosis of the main trunk of the portal vein. Cancer 1997;79:1890-6.
34. Chung YH, Song IH, Song BC, et al. Combined therapy consisting of intra-arterial cisplatin infusion and systemic interferon-a for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis. Cancer 2000;88:1986-91.
35. Toyoda G, Nakano S, Kumada T, et al. The efficacy of continuous arterial infusion of 5-fluorouracil and cisplatin through an implanted reservoir for severe advanced hepatocellular carcinoma. Oncology 1995;55:295-9.